Comparative toxicity of the cardiovacular toxin allylamine to porcine aortic smooth muscle and endothelial cells

Robert M. Hysmith, Paul J. Boor

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This study supports a recent hypothesis that the cardiovascular toxin, allylamine, is toxic to smooth muscle cells of large elastic arteries (aorta). Cultures of the porcine aortic smooth muscle, endothelial, and fibroblastic cells were exposed to varying concentrations of allylamine ranging from 5 μM to 340 μM. Monitored cytotoxic and cytolytic activities demonstrated that final concentrations of 60 μM allylamine decreased cell population viability of smooth muscle cells as much as 50%. Viability decreased approximately linearly with increasing concentrations of allylamine including spontaneous lysing of smooth muscle cells at 90 μM. Endothelial cells were more resistant to lower concentrations of allylamine requiring 90 μM to decrease cell population viability by 50%. In contrast, fibroblastic cells were very resistant to lower concentrations of allylamine. The specific lytic response of these cells in culture, measured by release of [3H]thymidine, gave findings parallel to the viability studies, i.e. at 100 μM allylamine smooth muscle cells demonstrated 75% specific lysis while endothelial cells showed 29%. Growth studies of cells surviving an 8-h exposure to allylamine indicate that surviving endothelial cells have better growth characteristics than surviving smooth muscle cells; both cell lines are also apparently injured at concentrations of allylamine much lower than the CT50. These studies show that of the cellular components of the vascular wall, smooth muscle cells appear to be the most sensitive to the toxic effects of allylamine.

Original languageEnglish (US)
Pages (from-to)141-150
Number of pages10
JournalToxicology
Volume38
Issue number2
DOIs
StatePublished - 1986

Fingerprint

Allylamine
Endothelial cells
Smooth Muscle Myocytes
Toxicity
Muscle
Swine
Endothelial Cells
Cells
Poisons
Cell Survival
Population Dynamics
Growth
Vascular Smooth Muscle
Cell culture
Thymidine
Smooth Muscle
Aorta
Arteries
Cell Culture Techniques

Keywords

  • Allylamine
  • Cytotoxicity
  • Endothelial cells
  • Smooth muscle cells

ASJC Scopus subject areas

  • Toxicology

Cite this

Comparative toxicity of the cardiovacular toxin allylamine to porcine aortic smooth muscle and endothelial cells. / Hysmith, Robert M.; Boor, Paul J.

In: Toxicology, Vol. 38, No. 2, 1986, p. 141-150.

Research output: Contribution to journalArticle

@article{db5f950473cd469ba802536754d92ab3,
title = "Comparative toxicity of the cardiovacular toxin allylamine to porcine aortic smooth muscle and endothelial cells",
abstract = "This study supports a recent hypothesis that the cardiovascular toxin, allylamine, is toxic to smooth muscle cells of large elastic arteries (aorta). Cultures of the porcine aortic smooth muscle, endothelial, and fibroblastic cells were exposed to varying concentrations of allylamine ranging from 5 μM to 340 μM. Monitored cytotoxic and cytolytic activities demonstrated that final concentrations of 60 μM allylamine decreased cell population viability of smooth muscle cells as much as 50{\%}. Viability decreased approximately linearly with increasing concentrations of allylamine including spontaneous lysing of smooth muscle cells at 90 μM. Endothelial cells were more resistant to lower concentrations of allylamine requiring 90 μM to decrease cell population viability by 50{\%}. In contrast, fibroblastic cells were very resistant to lower concentrations of allylamine. The specific lytic response of these cells in culture, measured by release of [3H]thymidine, gave findings parallel to the viability studies, i.e. at 100 μM allylamine smooth muscle cells demonstrated 75{\%} specific lysis while endothelial cells showed 29{\%}. Growth studies of cells surviving an 8-h exposure to allylamine indicate that surviving endothelial cells have better growth characteristics than surviving smooth muscle cells; both cell lines are also apparently injured at concentrations of allylamine much lower than the CT50. These studies show that of the cellular components of the vascular wall, smooth muscle cells appear to be the most sensitive to the toxic effects of allylamine.",
keywords = "Allylamine, Cytotoxicity, Endothelial cells, Smooth muscle cells",
author = "Hysmith, {Robert M.} and Boor, {Paul J.}",
year = "1986",
doi = "10.1016/0300-483X(86)90115-0",
language = "English (US)",
volume = "38",
pages = "141--150",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Comparative toxicity of the cardiovacular toxin allylamine to porcine aortic smooth muscle and endothelial cells

AU - Hysmith, Robert M.

AU - Boor, Paul J.

PY - 1986

Y1 - 1986

N2 - This study supports a recent hypothesis that the cardiovascular toxin, allylamine, is toxic to smooth muscle cells of large elastic arteries (aorta). Cultures of the porcine aortic smooth muscle, endothelial, and fibroblastic cells were exposed to varying concentrations of allylamine ranging from 5 μM to 340 μM. Monitored cytotoxic and cytolytic activities demonstrated that final concentrations of 60 μM allylamine decreased cell population viability of smooth muscle cells as much as 50%. Viability decreased approximately linearly with increasing concentrations of allylamine including spontaneous lysing of smooth muscle cells at 90 μM. Endothelial cells were more resistant to lower concentrations of allylamine requiring 90 μM to decrease cell population viability by 50%. In contrast, fibroblastic cells were very resistant to lower concentrations of allylamine. The specific lytic response of these cells in culture, measured by release of [3H]thymidine, gave findings parallel to the viability studies, i.e. at 100 μM allylamine smooth muscle cells demonstrated 75% specific lysis while endothelial cells showed 29%. Growth studies of cells surviving an 8-h exposure to allylamine indicate that surviving endothelial cells have better growth characteristics than surviving smooth muscle cells; both cell lines are also apparently injured at concentrations of allylamine much lower than the CT50. These studies show that of the cellular components of the vascular wall, smooth muscle cells appear to be the most sensitive to the toxic effects of allylamine.

AB - This study supports a recent hypothesis that the cardiovascular toxin, allylamine, is toxic to smooth muscle cells of large elastic arteries (aorta). Cultures of the porcine aortic smooth muscle, endothelial, and fibroblastic cells were exposed to varying concentrations of allylamine ranging from 5 μM to 340 μM. Monitored cytotoxic and cytolytic activities demonstrated that final concentrations of 60 μM allylamine decreased cell population viability of smooth muscle cells as much as 50%. Viability decreased approximately linearly with increasing concentrations of allylamine including spontaneous lysing of smooth muscle cells at 90 μM. Endothelial cells were more resistant to lower concentrations of allylamine requiring 90 μM to decrease cell population viability by 50%. In contrast, fibroblastic cells were very resistant to lower concentrations of allylamine. The specific lytic response of these cells in culture, measured by release of [3H]thymidine, gave findings parallel to the viability studies, i.e. at 100 μM allylamine smooth muscle cells demonstrated 75% specific lysis while endothelial cells showed 29%. Growth studies of cells surviving an 8-h exposure to allylamine indicate that surviving endothelial cells have better growth characteristics than surviving smooth muscle cells; both cell lines are also apparently injured at concentrations of allylamine much lower than the CT50. These studies show that of the cellular components of the vascular wall, smooth muscle cells appear to be the most sensitive to the toxic effects of allylamine.

KW - Allylamine

KW - Cytotoxicity

KW - Endothelial cells

KW - Smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=0022629904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022629904&partnerID=8YFLogxK

U2 - 10.1016/0300-483X(86)90115-0

DO - 10.1016/0300-483X(86)90115-0

M3 - Article

C2 - 3945966

AN - SCOPUS:0022629904

VL - 38

SP - 141

EP - 150

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 2

ER -